Copyright Reports & Markets. All rights reserved.

Global Computational Toxicology Platform Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Computational Toxicology Platform by Type
    • 1.3.1 Overview: Global Computational Toxicology Platform Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Computational Toxicology Platform Consumption Value Market Share by Type in 2025
    • 1.3.3 Cloud-Based Platform
    • 1.3.4 On-Premises Software
    • 1.3.5 Hybrid Deployment
  • 1.4 Classification of Computational Toxicology Platform by Modeling Approach
    • 1.4.1 Overview: Global Computational Toxicology Platform Market Size by Modeling Approach: 2021 Versus 2025 Versus 2032
    • 1.4.2 Global Computational Toxicology Platform Consumption Value Market Share by Modeling Approach in 2025
    • 1.4.3 Knowledge-Based Expert Systems
    • 1.4.4 Statistical QSAR Platforms
    • 1.4.5 Machine Learning and Deep Learning Platforms
    • 1.4.6 Mechanistic and Systems Toxicology Platforms
    • 1.4.7 Integrated Hybrid Platforms
  • 1.5 Classification of Computational Toxicology Platform by Toxicity Coverage
    • 1.5.1 Overview: Global Computational Toxicology Platform Market Size by Toxicity Coverage: 2021 Versus 2025 Versus 2032
    • 1.5.2 Global Computational Toxicology Platform Consumption Value Market Share by Toxicity Coverage in 2025
    • 1.5.3 Broad-Spectrum Multi-Endpoint Platforms
    • 1.5.4 Genotoxicity and Carcinogenicity Platforms
    • 1.5.5 Organ-Specific Toxicity Platforms
    • 1.5.6 Safety Pharmacology and Off-Target Platforms
    • 1.5.7 Ecotoxicity and Environmental Fate Platforms
  • 1.6 Classification of Computational Toxicology Platform by Platform Scope
    • 1.6.1 Overview: Global Computational Toxicology Platform Market Size by Platform Scope: 2021 Versus 2025 Versus 2032
    • 1.6.2 Global Computational Toxicology Platform Consumption Value Market Share by Platform Scope in 2025
    • 1.6.3 Standalone Endpoint Predictors
    • 1.6.4 Modular Toxicology Suites
    • 1.6.5 Integrated ADME/Tox Platforms
    • 1.6.6 Enterprise Toxicology Workbenches
  • 1.7 Global Computational Toxicology Platform Market by Application
    • 1.7.1 Overview: Global Computational Toxicology Platform Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.7.2 Pharmaceutical and Biotechnology
    • 1.7.3 Chemicals and Materials
    • 1.7.4 Agrochemicals
    • 1.7.5 Cosmetics and Consumer Products
    • 1.7.6 Government and Regulatory Agencies
    • 1.7.7 Academic and Contract Research
  • 1.8 Global Computational Toxicology Platform Market Size & Forecast
  • 1.9 Global Computational Toxicology Platform Market Size and Forecast by Region
    • 1.9.1 Global Computational Toxicology Platform Market Size by Region: 2021 VS 2025 VS 2032
    • 1.9.2 Global Computational Toxicology Platform Market Size by Region, (2021-2032)
    • 1.9.3 North America Computational Toxicology Platform Market Size and Prospect (2021-2032)
    • 1.9.4 Europe Computational Toxicology Platform Market Size and Prospect (2021-2032)
    • 1.9.5 Asia-Pacific Computational Toxicology Platform Market Size and Prospect (2021-2032)
    • 1.9.6 South America Computational Toxicology Platform Market Size and Prospect (2021-2032)
    • 1.9.7 Middle East & Africa Computational Toxicology Platform Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Certara
    • 2.1.1 Certara Details
    • 2.1.2 Certara Major Business
    • 2.1.3 Certara Computational Toxicology Platform Product and Solutions
    • 2.1.4 Certara Computational Toxicology Platform Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Certara Recent Developments and Future Plans
  • 2.2 Dassault Systèmes
    • 2.2.1 Dassault Systèmes Details
    • 2.2.2 Dassault Systèmes Major Business
    • 2.2.3 Dassault Systèmes Computational Toxicology Platform Product and Solutions
    • 2.2.4 Dassault Systèmes Computational Toxicology Platform Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Dassault Systèmes Recent Developments and Future Plans
  • 2.3 Schrödinger
    • 2.3.1 Schrödinger Details
    • 2.3.2 Schrödinger Major Business
    • 2.3.3 Schrödinger Computational Toxicology Platform Product and Solutions
    • 2.3.4 Schrödinger Computational Toxicology Platform Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Schrödinger Recent Developments and Future Plans
  • 2.4 Simulations Plus
    • 2.4.1 Simulations Plus Details
    • 2.4.2 Simulations Plus Major Business
    • 2.4.3 Simulations Plus Computational Toxicology Platform Product and Solutions
    • 2.4.4 Simulations Plus Computational Toxicology Platform Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Simulations Plus Recent Developments and Future Plans
  • 2.5 Lhasa
    • 2.5.1 Lhasa Details
    • 2.5.2 Lhasa Major Business
    • 2.5.3 Lhasa Computational Toxicology Platform Product and Solutions
    • 2.5.4 Lhasa Computational Toxicology Platform Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Lhasa Recent Developments and Future Plans
  • 2.6 Instem
    • 2.6.1 Instem Details
    • 2.6.2 Instem Major Business
    • 2.6.3 Instem Computational Toxicology Platform Product and Solutions
    • 2.6.4 Instem Computational Toxicology Platform Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Instem Recent Developments and Future Plans
  • 2.7 Elsevier
    • 2.7.1 Elsevier Details
    • 2.7.2 Elsevier Major Business
    • 2.7.3 Elsevier Computational Toxicology Platform Product and Solutions
    • 2.7.4 Elsevier Computational Toxicology Platform Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Elsevier Recent Developments and Future Plans
  • 2.8 Clarivate
    • 2.8.1 Clarivate Details
    • 2.8.2 Clarivate Major Business
    • 2.8.3 Clarivate Computational Toxicology Platform Product and Solutions
    • 2.8.4 Clarivate Computational Toxicology Platform Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Clarivate Recent Developments and Future Plans
  • 2.9 ACD/Labs
    • 2.9.1 ACD/Labs Details
    • 2.9.2 ACD/Labs Major Business
    • 2.9.3 ACD/Labs Computational Toxicology Platform Product and Solutions
    • 2.9.4 ACD/Labs Computational Toxicology Platform Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 ACD/Labs Recent Developments and Future Plans
  • 2.10 Optibrium
    • 2.10.1 Optibrium Details
    • 2.10.2 Optibrium Major Business
    • 2.10.3 Optibrium Computational Toxicology Platform Product and Solutions
    • 2.10.4 Optibrium Computational Toxicology Platform Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Optibrium Recent Developments and Future Plans
  • 2.11 MultiCASE
    • 2.11.1 MultiCASE Details
    • 2.11.2 MultiCASE Major Business
    • 2.11.3 MultiCASE Computational Toxicology Platform Product and Solutions
    • 2.11.4 MultiCASE Computational Toxicology Platform Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 MultiCASE Recent Developments and Future Plans
  • 2.12 Chemical Computing Group
    • 2.12.1 Chemical Computing Group Details
    • 2.12.2 Chemical Computing Group Major Business
    • 2.12.3 Chemical Computing Group Computational Toxicology Platform Product and Solutions
    • 2.12.4 Chemical Computing Group Computational Toxicology Platform Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Chemical Computing Group Recent Developments and Future Plans
  • 2.13 Molecular Networks
    • 2.13.1 Molecular Networks Details
    • 2.13.2 Molecular Networks Major Business
    • 2.13.3 Molecular Networks Computational Toxicology Platform Product and Solutions
    • 2.13.4 Molecular Networks Computational Toxicology Platform Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Molecular Networks Recent Developments and Future Plans
  • 2.14 ProtoQSAR
    • 2.14.1 ProtoQSAR Details
    • 2.14.2 ProtoQSAR Major Business
    • 2.14.3 ProtoQSAR Computational Toxicology Platform Product and Solutions
    • 2.14.4 ProtoQSAR Computational Toxicology Platform Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 ProtoQSAR Recent Developments and Future Plans
  • 2.15 KREATiS
    • 2.15.1 KREATiS Details
    • 2.15.2 KREATiS Major Business
    • 2.15.3 KREATiS Computational Toxicology Platform Product and Solutions
    • 2.15.4 KREATiS Computational Toxicology Platform Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 KREATiS Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Computational Toxicology Platform Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Computational Toxicology Platform by Company Revenue
    • 3.2.2 Top 3 Computational Toxicology Platform Players Market Share in 2025
    • 3.2.3 Top 6 Computational Toxicology Platform Players Market Share in 2025
  • 3.3 Computational Toxicology Platform Market: Overall Company Footprint Analysis
    • 3.3.1 Computational Toxicology Platform Market: Region Footprint
    • 3.3.2 Computational Toxicology Platform Market: Company Product Type Footprint
    • 3.3.3 Computational Toxicology Platform Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Computational Toxicology Platform Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Computational Toxicology Platform Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Computational Toxicology Platform Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Computational Toxicology Platform Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Computational Toxicology Platform Consumption Value by Type (2021-2032)
  • 6.2 North America Computational Toxicology Platform Market Size by Application (2021-2032)
  • 6.3 North America Computational Toxicology Platform Market Size by Country
    • 6.3.1 North America Computational Toxicology Platform Consumption Value by Country (2021-2032)
    • 6.3.2 United States Computational Toxicology Platform Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Computational Toxicology Platform Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Computational Toxicology Platform Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Computational Toxicology Platform Consumption Value by Type (2021-2032)
  • 7.2 Europe Computational Toxicology Platform Consumption Value by Application (2021-2032)
  • 7.3 Europe Computational Toxicology Platform Market Size by Country
    • 7.3.1 Europe Computational Toxicology Platform Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Computational Toxicology Platform Market Size and Forecast (2021-2032)
    • 7.3.3 France Computational Toxicology Platform Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Computational Toxicology Platform Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Computational Toxicology Platform Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Computational Toxicology Platform Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Computational Toxicology Platform Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Computational Toxicology Platform Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Computational Toxicology Platform Market Size by Region
    • 8.3.1 Asia-Pacific Computational Toxicology Platform Consumption Value by Region (2021-2032)
    • 8.3.2 China Computational Toxicology Platform Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Computational Toxicology Platform Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Computational Toxicology Platform Market Size and Forecast (2021-2032)
    • 8.3.5 India Computational Toxicology Platform Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Computational Toxicology Platform Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Computational Toxicology Platform Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Computational Toxicology Platform Consumption Value by Type (2021-2032)
  • 9.2 South America Computational Toxicology Platform Consumption Value by Application (2021-2032)
  • 9.3 South America Computational Toxicology Platform Market Size by Country
    • 9.3.1 South America Computational Toxicology Platform Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Computational Toxicology Platform Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Computational Toxicology Platform Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Computational Toxicology Platform Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Computational Toxicology Platform Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Computational Toxicology Platform Market Size by Country
    • 10.3.1 Middle East & Africa Computational Toxicology Platform Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Computational Toxicology Platform Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Computational Toxicology Platform Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Computational Toxicology Platform Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Computational Toxicology Platform Market Drivers
  • 11.2 Computational Toxicology Platform Market Restraints
  • 11.3 Computational Toxicology Platform Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Computational Toxicology Platform Industry Chain
  • 12.2 Computational Toxicology Platform Upstream Analysis
  • 12.3 Computational Toxicology Platform Midstream Analysis
  • 12.4 Computational Toxicology Platform Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Computational Toxicology Platform market size was valued at US$ 1317 million in 2025 and is forecast to a readjusted size of US$ 3120 million by 2032 with a CAGR of 13.1% during review period.
    A computational toxicology platform is a software environment that uses chemical structures, in vitro and in vivo toxicology data, pharmacokinetic information, omics data, and adverse-event evidence to predict toxicity endpoints, dose-response relationships, target-organ risks, and environmental hazards through structural alerts, QSAR, machine learning, read-across, PBPK/QST, and mechanistic models. Typical functions include applicability-domain assessment, uncertainty analysis, analogue searching, weight-of-evidence workflows, batch screening, and regulatory-ready reporting for early safety evaluation of pharmaceuticals, chemicals, agrochemicals, and consumer products, with an estimated gross margin of approximately 75%.
    Demand is driven by early elimination of high-risk drug candidates, regulatory assessment of chemicals and agrochemicals, consumer-product safety screening, and policies that encourage reduced reliance on animal testing. As the chemical space requiring assessment expands and laboratory toxicology remains costly and time-consuming, computational prediction is moving upstream into molecular design, candidate prioritization, and test-planning workflows.
    Product development is shifting toward unified workflows that combine structural alerts, statistical QSAR, deep learning, read-across, exposure modeling, and systems toxicology, with stronger applicability-domain controls, uncertainty estimates, explainability, and evidence traceability. Cloud batch computing, APIs, private-data model building, and automated regulatory reporting are becoming key purchasing criteria, while single-endpoint tools are evolving into multi-endpoint, multi-evidence platforms.
    Competitive strength depends on proprietary curated datasets, regulatory validation experience, endpoint depth, and enterprise deployment capabilities. European and North American vendors remain strong in pharmaceutical and regulatory use cases, while specialist QSAR suppliers retain defensible positions in genotoxicity and ecotoxicity. Local datasets, regional regulatory support, and links to experimental platforms create opportunities for new entrants, although model extrapolation risk, data bias, uneven regulatory acceptance, and customer validation costs will slow full replacement of laboratory testing.
    Report Scope
    This report is a detailed and comprehensive analysis for global Computational Toxicology Platform market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Computational Toxicology Platform market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Computational Toxicology Platform market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Computational Toxicology Platform market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Computational Toxicology Platform market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Computational Toxicology Platform
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Computational Toxicology Platform market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Certara, Dassault Systèmes, Schrödinger, Simulations Plus, Lhasa, Instem, Elsevier, Clarivate, ACD/Labs, Optibrium, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Computational Toxicology Platform market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Cloud-Based Platform
    On-Premises Software
    Hybrid Deployment
    Market segment by Modeling Approach
    Knowledge-Based Expert Systems
    Statistical QSAR Platforms
    Machine Learning and Deep Learning Platforms
    Mechanistic and Systems Toxicology Platforms
    Integrated Hybrid Platforms
    Market segment by Toxicity Coverage
    Broad-Spectrum Multi-Endpoint Platforms
    Genotoxicity and Carcinogenicity Platforms
    Organ-Specific Toxicity Platforms
    Safety Pharmacology and Off-Target Platforms
    Ecotoxicity and Environmental Fate Platforms
    Market segment by Platform Scope
    Standalone Endpoint Predictors
    Modular Toxicology Suites
    Integrated ADME/Tox Platforms
    Enterprise Toxicology Workbenches
    Market segment by Application
    Pharmaceutical and Biotechnology
    Chemicals and Materials
    Agrochemicals
    Cosmetics and Consumer Products
    Government and Regulatory Agencies
    Academic and Contract Research
    Market segment by players, this report covers
    Certara
    Dassault Systèmes
    Schrödinger
    Simulations Plus
    Lhasa
    Instem
    Elsevier
    Clarivate
    ACD/Labs
    Optibrium
    MultiCASE
    Chemical Computing Group
    Molecular Networks
    ProtoQSAR
    KREATiS
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    Chapter Outline
    Chapter 1, to describe Computational Toxicology Platform product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Computational Toxicology Platform, with revenue, gross margin, and global market share of Computational Toxicology Platform from 2021 to 2026.
    Chapter 3, the Computational Toxicology Platform competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Computational Toxicology Platform market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Computational Toxicology Platform.
    Chapter 13, to describe Computational Toxicology Platform research findings and conclusion.

    Buy now